BioCryst’s Zika Drug Shows Promise in Mice By Drug Discovery Trends Editor | March 7, 2016BioCryst Pharmaceuticals Inc said on Monday a dose of its experimental antiviral drug improved survival rates in mice infected with the Zika virus in a preclinical study. Read more. Source: Reuters Filed Under: Drug Discovery
The return on engagement: How sustained community outreach is improving clinical trial representation